4.8 Article

The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells

Journal

CELL
Volume 138, Issue 3, Pages 449-462

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2009.05.035

Keywords

-

Funding

  1. Max-Planck Society
  2. Dr. H. Storz and Alte Leipziger Foundation
  3. INSERM
  4. INSERM-Avenir Program
  5. National Fund for Scientific Research-FlanderS [G000609N10]
  6. Juvenile Diabetes Research foundation [26-2008-639]
  7. National Institutes of Health Beta Cell Biology Consortium [U19 DK 072495-01]

Ask authors/readers for more resources

We have previously reported that the loss of Arx and/or Pax4 gene activity leads to a shift in the fate of the different endocrine cell subtypes in the mouse pancreas, without affecting the total endocrine cell numbers. Here, we conditionally and ectopically express Pax4 using different cell-specific promoters and demonstrate that Pax4 forces endocrine precursor cells, as well as mature alpha cells, to adopt a beta cell destiny. This results in a glucagon deficiency that provokes a compensatory and continuous glucagon(+) cell neogenesis requiring the re-expression of the pro-endocrine gene Ngn3. However, the newly formed alpha cells fail to correct the hypoglucagonemia since they subsequently acquire a beta cell phenotype upon Pax4 ectopic expression. Notably, this cycle of neogenesis and redifferentiation caused by ectopic expression of Pax4 in alpha cells is capable of restoring a functional beta cellmass and curing diabetes in animals that have been chemically depleted of beta cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available